EXOC8
protein-codingexocyst complex component 8, the group of Exocyst complex|Pleckstrin homology domain containing
Gene summary
This gene encodes a component of the exocyst complex, an evolutionarily conserved multi-protein complex that plays a critical role in vesicular trafficking and the secretory pathway by targeting post-Golgi vesicles to the plasma membrane. This protein is a target of activated Ral subfamily of GTPases and thereby regulates exocytosis by tethering vesicles to the plasma membrane. Mutations in this gene may be related to Joubert syndrome. [provided by RefSeq, Sep 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0033662
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0033662
Submitter: LiferaOmics
Genetic evidence – Published: PMID: 32103185 – Reports 1 family with a homozygous truncating (pLOF) EXOC8 variant (Asp607Ter) and phenotype including severe developmental delay, seizures, microcephaly, brain atrophy, and early death. Case-level (biallelic predicted null in AR model; homozygous scored once; no consanguinity deduction applied as not specified) = 1.5; segregation (familial support; conservative) = 0.5; case-control = 0. PMID: 35460391 – Reports a large consanguineous family with multiple affected individuals homozygous for a nonsense (pLOF) EXOC8 variant with consistent neurodevelopmental phenotype (microcephaly, seizures, developmental delay, brain atrophy). Case-level (biallelic predicted null; homozygous scored once; −0.5 consanguinity deduction applied) = 1.0; segregation (affected relatives; conservative) = 0.5; case-control = 0. Published genetic evidence total = case-level (1.5 + 1.0 = 2.5) + segregation (0.5 + 0.5 = 1.0) = 3.5/12. Genetic evidence – our case: 1 proband; homozygous predicted loss-of-function frameshift variant; autosomal recessive inheritance; consanguinity not specified; no additional genotyped affected relatives; no segregation or case-control data. Case-level (biallelic predicted null in AR model; homozygous scored once; no consanguinity deduction applied as not specified) = 1.5; segregation = 0; case-control = 0. Current case contribution = 1.5/12. Total genetic evidence (published + our case) = 5.0/12. Experimental evidence – Published: EXOC8 encodes a component of the exocyst complex involved in vesicle trafficking and neuronal development (biochemical function/biological plausibility) = 0.5. Model system and pathway-level evidence cited in GenCC (including PMID: 27626380, high-throughput mouse phenotyping showing developmental abnormalities in exocyst-related genes) provides supportive but not phenotype-specific functional evidence = 1.5. Experimental evidence total = 2.0/6. Overall score = 7.0
Inheritance Pattern: AR
Disease ID:MONDO:0033662
Submitter: Labcorp Genetics (formerly Invitae)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EXOC8 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_175876.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 4 | 17 | |||
| missense | 80 | 2 | 2 | 84 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | 4 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 2 | 82 | 15 | 6 | 105 |
Highest pathogenic variant AF is 0.0000043369596
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_787072.2 | 1 | MANE Select | |
| Ensembl | ENSP00000355605.2 | 1 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- RalA downstream regulated genes
- VxPx cargo-targeting to cilium
- Cargo trafficking to the periciliary membrane
- Cilium Assembly
- Organelle biogenesis and maintenance
Biological Process
- exocyst assembly
- endosome organization
- protein transport
- regulation of macroautophagy
- extracellular matrix disassembly
Molecular Function
- protein binding
- Ral GTPase binding
Cellular Component
- exocyst
- late endosome
- cytosol
- plasma membrane
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000360394
- Coding exons
- 1
- Length
- 5119
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.04 | 294 | 410 | 0.716 | 0.0000206 | 4730 |
| Missense (PolyPhen) | 54 | 116.93 | 0.4618 | 1309 | ||
| Synonymous | -0.0547 | 171 | 170 | 1.01 | 0.00000881 | 1473 |
| Loss of Function | 4.40 | 1 | 24.5 | 0.0408 | 0.00000141 | 259 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- LoFtool
- 0.117
- RVIS EVS
- -0.49
- RVIS percentile EVS
- 22.65
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Indispensability pred.
- E
- Indispensability score
- 0.946
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |